LIDDS
0,13 SEK 0%1 investor følger denne virksomhed
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patent-protected and clinically tested drug delivery technology. The properties of the products form the basis of LIDDS 'technology platform for the development of injectable drug products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System and the company is headquartered in Uppsala.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
LIDDS
Daglig lav / høj pris
0,129 / 0,13
SEK
Markedsværdi
17,74 mio. SEK
Aktieomsætning
8,5 t SEK
Volumen
65 t
Finanskalender
Delårsrapport
28.08.2024
Delårsrapport
21.11.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 13,4 % | 13,4 % |
Wikow Venture | 6,1 % | 6,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Bulletin from the Annual General Meeting in LIDDS AB (PUBL) on 27 May 2024
LIDDS moves the publication of the Interim Report for the first quarter 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools